Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06324786
Other study ID # 2024 IBMT NF
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date August 31, 2026

Study information

Verified date March 2024
Source Arizona State University
Contact YiYuan Tang
Phone 4807903577
Email yiyuan@asu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.


Description:

The proposed study will test whether real-time NF could optimize IBMT practice and improve effects in reducing polysubstance use through targeting self-control networks in the brain.


Recruitment information / eligibility

Status Recruiting
Enrollment 35
Est. completion date August 31, 2026
Est. primary completion date August 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years old - Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis) - In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month - Normal or corrected-to-normal vision - Written informed consent - No previous meditation or NF experiences Exclusion Criteria: - Any psychiatric diagnoses other than an SUD - Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females) - Excluding cannabis, evidence of recent (past month) illicit drug use

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
IBMT
IBMT is an effortless mindfulness technique
NF
NF is a mental training technique.

Locations

Country Name City State
United States YiYuan Tang Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Arizona State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI) Brain connectivity changes such as anterior and posterior cingulate cortex measured by fMRI resting state imaging The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Primary Intervention effects on brain white matter using fMRI Brain white matter changes such as anterior and posterior cingulate cortex measured by fMRI diffusion tensor imaging The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Primary Intervention effects on brain grey matter using fMRI Brain volume changes such as anterior and posterior cingulate cortex measured by fMRI structural imaging The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Secondary Intervention effects on addiction behavior using substance use questionnaires in PhenX Toolkit Intervention leads to a significant reduction in craving and substance use measured by substance use questionnaires in PhenX Toolkit The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
See also
  Status Clinical Trial Phase
Completed NCT06214130 - Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets Phase 1
Completed NCT01689493 - Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation N/A
Recruiting NCT01758679 - A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma Phase 4
Completed NCT04261504 - Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention N/A